Skip to main content
Rallis India Ltd logo

Rallis India Ltd — Investor Relations & Filings

Ticker · RALLIS ISIN · INE613A01020 LEI · 335800HI7I928BFJB442 BSE.NS Manufacturing
Open in API
Filings indexed 1,579 across all filing types
Latest filing 2025-12-08 Board/Management Inform…
Country IN India
Listing BSE.NS RALLIS

About Rallis India Ltd

https://www.rallis.com/

Rallis India Ltd, a subsidiary of Tata Chemicals and a member of the Tata Group, specializes in providing comprehensive crop care solutions. The company's core business activities encompass the manufacturing and marketing of a diverse portfolio of agrochemicals, including insecticides, fungicides, and herbicides. Additionally, it maintains a significant presence in the seeds business, developing high-yielding hybrids for crops such as maize, paddy, and pearl millet. Rallis also offers plant growth nutrients and soil conditioners to enhance agricultural productivity. With a robust research and development framework and a vast distribution network, the company serves both domestic and international markets, exporting products to over 70 countries. Its operations are supported by integrated manufacturing facilities and a commitment to sustainable agricultural practices, positioning it as a key partner in the global agricultural value chain.

Recent filings

Filing Released Lang Actions
Appointment of Mr. Mahesh Girdhar (DIN: 10270848) as an Additional Director (Non-Executive, Independent)
Board/Management Information Classification · 95% confidence The document is a formal announcement addressed to stock exchanges regarding the appointment of Mr. Mahesh Girdhar as an Additional Director (Non-Executive, Independent) of the company. It references compliance with SEBI Listing Regulations and includes detailed disclosures about the appointment, term, and profile of the director. There are no financial statements, earnings data, or report publications. The content clearly pertains to a change in the company's board of directors, which fits the category of Board/Management Information (MANG). The document length is about 5308 characters, sufficient for a detailed announcement but not a full report. Therefore, the appropriate classification is MANG with high confidence.
2025-12-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the schedule of meetings with analysts and institutional investors. It references SEBI Listing Obligations and Disclosure Requirements Regulation 30(6), which mandates disclosure of such meetings. The content is an announcement of a scheduled investor meeting, explicitly stating no unpublished price sensitive information will be shared. The document is short (1632 characters) and does not contain any financial data, results, or detailed presentations. It is not a report, earnings release, or investor presentation but an update about upcoming investor engagement. Therefore, it fits best under Capital/Financing Update (CAP), which includes updates on company fundraising, financing activities, or capital structure changes, and often includes investor meetings and related disclosures under SEBI regulations.
2025-12-02 English
This has reference to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In accordance with the said Regulation(s), please find enclosed ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the schedule of meetings with analysts and institutional investors. It references SEBI Listing Obligations and Disclosure Requirements Regulation 30(6), which pertains to disclosure of events or information. The content is about informing the exchanges and public about upcoming investor meetings, explicitly stating no unpublished price sensitive information will be shared. The document is short (1632 characters) and does not contain any financial data, results, or detailed presentations. It is an announcement of a meeting schedule rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2025-12-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the schedule of meetings with analysts and institutional investors. It references SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30(6), which pertains to disclosure of events or information. The content is an intimation about upcoming meetings and explicitly states that no unpublished price sensitive information will be shared. The document is short (1629 characters) and serves as a notification rather than a detailed report or transcript. It does not contain financial data, earnings, or detailed presentations. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2025-11-20 English
This has reference to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In accordance with the said Regulation(s), please find enclosed the ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the schedule of meetings with analysts and institutional investors. It references SEBI Listing Obligations and Disclosure Requirements Regulation 30(6), which mandates disclosure of such meetings. The document explicitly states it is an intimation of the schedule of analysts/investors meetings and clarifies that no unpublished price sensitive information will be shared. The document is short (1629 characters) and serves as a notification rather than a detailed report or transcript. It does not contain financial data, earnings, or detailed presentations. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and compliance disclosure under SEBI regulations.
2025-11-20 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing a partnership between Rallis India Limited and Paryan Alliance for a new herbicide tolerance rice technology. It contains no financial data, no regulatory filing references, no voting results, no management or board changes, no earnings or annual report content. It is a corporate announcement about a business collaboration and technology introduction. The document explicitly states it is a press release and not a regulatory disclosure under SEBI regulations. Therefore, it does not fit into financial report categories like 10-K, IR, ER, or regulatory filings. It is not a report publication announcement either, as it is a standalone press release. The best fitting category is Regulatory Filings (RNS) as a general corporate announcement that does not fit other specific categories.
2025-11-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.